Cargando…

Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel

We report the utility of rapid antigen tests (RAgT) in a cohort of US healthcare personnel with coronavirus disease 2019 (COVID-19) infection who met symptom criteria to return to work at day 5 or later of isolation. In total, 11.9% of initial RAgT were negative. RAgT can be helpful to guide return...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tande, Aaron J, Swift, Melanie D, Challener, Douglas W, Berbari, Elie F, Tommaso, Christopher P, Christopherson, Darrin R, Binnicker, Matthew J, Breeher, Laura E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129106/ https://www.ncbi.nlm.nih.gov/pubmed/35352091 http://dx.doi.org/10.1093/cid/ciac235

Ejemplares similares

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel
por: Swift, Melanie D, et al.
Publicado: (2021)

Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening
por: Tande, Aaron J, et al.
Publicado: (2021)

Low Utility of Repeat Real-Time PCR Testing for SARS-CoV-2 in Clinical Specimens
por: Challener, Douglas W., et al.
Publicado: (2020)

In Reply—Repeated Testing in SARS-CoV-2 Infection
por: Shah, Aditya, et al.
Publicado: (2020)

Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area
por: Shah, Vishal P., et al.
Publicado: (2020)

Diagnostic Stewardship: An Essential Element in a Rapidly Evolving COVID-19 Pandemic
por: Shah, Aditya S., et al.
Publicado: (2020)

Healthcare personnel absenteeism, presenteeism, and staffing challenges during epidemics
por: Challener, Douglas W., et al.
Publicado: (2020)

Drive-Through Testing: A Unique, Efficient Method of Collecting Large Volume of Specimens During the SARS-CoV-2 (COVID-19) Pandemic
por: Shah, Aditya, et al.
Publicado: (2020)

Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone
por: Virk, Abinash, et al.
Publicado: (2023)

Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer
por: Bloch, Evan M, et al.
Publicado: (2021)

Healthcare personnel frequently have positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen tests 5 days or more after diagnosis of coronavirus disease 2019 (COVID-19)
por: Stiefel, Usha, et al.
Publicado: (2022)

Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States
por: Campbell, Michelle R., et al.
Publicado: (2022)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic
por: Rosser, Joelle I., et al.
Publicado: (2020)

Severe acute respiratory syndrome-coronavirus 2 and novel coronavirus disease 2019: An extraordinary pandemic
por: Singh, Sheetu, et al.
Publicado: (2020)

Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019
por: Karimi, Saeed, et al.
Publicado: (2020)

Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients with Coronavirus Disease 2019
por: Kim, Da Young, et al.
Publicado: (2021)

SARS-CoV-2 Testing Before International Airline Travel, December 2020 to May 2021
por: Tande, Aaron J., et al.
Publicado: (2021)

Large-Scale Testing of Asymptomatic Healthcare Personnel for Severe Acute Respiratory Syndrome Coronavirus 2
por: Hogan, Catherine A., et al.
Publicado: (2021)

The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
por: Sendi, Parham, et al.
Publicado: (2022)

The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure()
por: Angeli, Fabio, et al.
Publicado: (2023)

What are the sources of exposure in healthcare personnel with coronavirus disease 2019 infection?
por: Zabarsky, Trina F., et al.
Publicado: (2021)

451. Evaluation of Exposure History in Healthcare Personnel with Coronavirus 2019 Disease
por: Silva, Sandra, et al.
Publicado: (2020)

Minimal Population Prevalence and Mortality of Coronavirus Disease 2019 in Healthcare Personnel
por: Gupta, Kalpana, et al.
Publicado: (2020)

Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening
por: Stokes, Nadarra L., et al.
Publicado: (2021)

Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay( )
por: Sigal, George B, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 seroprevalence among personnel in the healthcare facilities of Croatia, 2020
por: Vilibic-Cavlek, Tatjana, et al.
Publicado: (2020)

COVID-19 Infections in Health Care Personnel by Source of Exposure and Correlation With Community Incidence
por: Wight, Elizabeth, et al.
Publicado: (2022)

Role of Acute Thrombosis in Coronavirus Disease 2019
por: Gibbs, Derek V., et al.
Publicado: (2022)

Acute Macular Neuroretinopathy and Coronavirus Disease 2019
por: Dinh, Russel H., et al.
Publicado: (2023)

Hunting coronavirus severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus): From laboratory testing back to basic research
por: Yang, De-Ming, et al.
Publicado: (2020)

Digital Health Surveillance Strategies for Management of Coronavirus Disease 2019
por: Jose, Thulasee, et al.
Publicado: (2020)

Comment on evidence for and against vertical transmission of severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019)
por: Brion, Luc Pierre, et al.
Publicado: (2020)

No evidence of severe acute respiratory syndrome–coronavirus 2 in semen of males recovering from coronavirus disease 2019
por: Pan, Feng, et al.
Publicado: (2020)

Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019
por: Regan, James, et al.
Publicado: (2021)

The use of simulation-CT’s as a coronavirus disease 2019 screening tool during the severe acute respiratory syndrome coronavirus 2 pandemic()
por: Nevens, Daan, et al.
Publicado: (2020)

Mass severe acute respiratory coronavirus 2 (SARS-CoV-2) testing of asymptomatic healthcare personnel – ERRATUM
por: Roberts, Scott C., et al.
Publicado: (2022)

Screening for canine coronavirus, canine influenza virus, and severe acute respiratory syndrome coronavirus 2 in dogs during the coronavirus disease-2019 pandemic
por: Santos, Hércules Otacílio, et al.
Publicado: (2023)

Genomic Investigation to Identify Sources of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Personnel in an Acute Care Hospital
por: Sansom, Sarah E, et al.
Publicado: (2022)

Diagnostic performance of antigen testing for severe acute respiratory syndrome coronavirus 2
por: Marchán-López, Álvaro, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses
por: Ogata, Alana F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7jhs06g4g5e9pirfeod4araii0